Literature DB >> 25074491

Insulin resistance, diabetes mellitus, and brain structure in bipolar disorders.

Tomas Hajek1, Cynthia Calkin2, Ryan Blagdon2, Claire Slaney2, Rudolf Uher2, Martin Alda1.   

Abstract

Type 2 diabetes mellitus (T2DM) damages the brain, especially the hippocampus, and frequently co-occurs with bipolar disorders (BD). Reduced hippocampal volumes are found only in some studies of BD subjects and may thus be secondary to the presence of certain clinical variables. Studying BD patients with abnormal glucose metabolism could help identify preventable risk factors for hippocampal atrophy in BD. We compared brain structure using optimized voxel-based morphometry of 1.5T MRI scans in 33 BD subjects with impaired glucose metabolism (19 with insulin resistance/glucose intolerance (IR/GI), 14 with T2DM), 15 euglycemic BD participants and 11 euglycemic, nonpsychiatric controls. The group of BD patients with IR, GI or T2DM had significantly smaller hippocampal volumes than the euglycemic BD participants (corrected p=0.02) or euglycemic, nonpsychiatric controls (corrected p=0.004). Already the BD subjects with IR/GI had smaller hippocampal volumes than euglycemic BD participants (t(32)=-3.15, p=0.004). Age was significantly more negatively associated with hippocampal volumes in BD subjects with IR/GI/T2DM than in the euglycemic BD participants (F(2, 44)=9.96, p=0.0003). The gray matter reductions in dysglycemic subjects extended to the cerebral cortex, including the insula. In conclusion, this is the first study demonstrating that T2DM or even prediabetes may be risk factors for smaller hippocampal and cortical volumes in BD. Abnormal glucose metabolism may accelerate the age-related decline in hippocampal volumes in BD. These findings raise the possibility that improving diabetes care among BD subjects and intervening already at the level of prediabetes could slow brain aging in BD.

Entities:  

Mesh:

Year:  2014        PMID: 25074491      PMCID: PMC4200504          DOI: 10.1038/npp.2014.148

Source DB:  PubMed          Journal:  Neuropsychopharmacology        ISSN: 0893-133X            Impact factor:   7.853


  49 in total

Review 1.  Grey matter differences in bipolar disorder: a meta-analysis of voxel-based morphometry studies.

Authors:  Sudhakar Selvaraj; Danilo Arnone; Dominic Job; Andrew Stanfield; Tom Fd Farrow; Allison C Nugent; Harald Scherk; Oliver Gruber; Xiaohua Chen; Perminder S Sachdev; Daniel P Dickstein; Gin S Malhi; Tae H Ha; Kyooseob Ha; Mary L Phillips; Andrew M McIntosh
Journal:  Bipolar Disord       Date:  2012-03       Impact factor: 6.744

Review 2.  Longitudinal neuroimaging and neuropsychological changes in bipolar disorder patients: review of the evidence.

Authors:  Chin Siang Lim; Ross J Baldessarini; Eduard Vieta; Murat Yucel; Emre Bora; Kang Sim
Journal:  Neurosci Biobehav Rev       Date:  2013-01-12       Impact factor: 8.989

Review 3.  The relationship between bipolar disorder and type 2 diabetes: more than just co-morbid disorders.

Authors:  Cynthia V Calkin; David M Gardner; Thomas Ransom; Martin Alda
Journal:  Ann Med       Date:  2012-05-24       Impact factor: 4.709

Review 4.  Diabetes and cognitive dysfunction.

Authors:  Rory J McCrimmon; Christopher M Ryan; Brian M Frier
Journal:  Lancet       Date:  2012-06-09       Impact factor: 79.321

5.  Smaller hippocampal volumes in patients with bipolar disorder are masked by exposure to lithium: a meta-analysis.

Authors:  Tomas Hajek; Miloslav Kopecek; Cyril Höschl; Martin Alda
Journal:  J Psychiatry Neurosci       Date:  2012-09       Impact factor: 6.186

6.  Large positive effect of lithium on prefrontal cortex N-acetylaspartate in patients with bipolar disorder: 2-centre study.

Authors:  Tomas Hajek; Michael Bauer; Andrea Pfennig; Jeffrey Cullis; Jana Ploch; Claire O'Donovan; Georg Bohner; Randolf Klingebiel; L Trevor Young; Glenda M Macqueen; Martin Alda
Journal:  J Psychiatry Neurosci       Date:  2012-05       Impact factor: 6.186

7.  Collaborative chronic care models for mental health conditions: cumulative meta-analysis and metaregression to guide future research and implementation.

Authors:  Christopher J Miller; Andrew Grogan-Kaylor; Brian E Perron; Amy M Kilbourne; Emily Woltmann; Mark S Bauer
Journal:  Med Care       Date:  2013-10       Impact factor: 2.983

8.  Insulin resistance, brain atrophy, and cognitive performance in late middle-aged adults.

Authors:  Auriel A Willette; Guofan Xu; Sterling C Johnson; Alex C Birdsill; Erin M Jonaitis; Mark A Sager; Bruce P Hermann; Asenath La Rue; Sanjay Asthana; Barbara B Bendlin
Journal:  Diabetes Care       Date:  2012-10-15       Impact factor: 19.112

9.  Brain atrophy in type 2 diabetes: regional distribution and influence on cognition.

Authors:  Chris Moran; Thanh G Phan; Jian Chen; Leigh Blizzard; Richard Beare; Alison Venn; Gerald Münch; Amanda G Wood; Josephine Forbes; Timothy M Greenaway; Susan Pearson; Velandai Srikanth
Journal:  Diabetes Care       Date:  2013-08-12       Impact factor: 19.112

10.  Progressive brain changes in schizophrenia related to antipsychotic treatment? A meta-analysis of longitudinal MRI studies.

Authors:  P Fusar-Poli; R Smieskova; M J Kempton; B C Ho; N C Andreasen; S Borgwardt
Journal:  Neurosci Biobehav Rev       Date:  2013-06-14       Impact factor: 8.989

View more
  18 in total

1.  Brain Age in Early Stages of Bipolar Disorders or Schizophrenia.

Authors:  Tomas Hajek; Katja Franke; Marian Kolenic; Jana Capkova; Martin Matejka; Lukas Propper; Rudolf Uher; Pavla Stopkova; Tomas Novak; Tomas Paus; Miloslav Kopecek; Filip Spaniel; Martin Alda
Journal:  Schizophr Bull       Date:  2019-01-01       Impact factor: 9.306

Review 2.  Insulin resistance takes center stage: a new paradigm in the progression of bipolar disorder.

Authors:  Cynthia V Calkin
Journal:  Ann Med       Date:  2019-08-27       Impact factor: 4.709

Review 3.  A review on shared clinical and molecular mechanisms between bipolar disorder and frontotemporal dementia.

Authors:  Camila Nascimento; Villela Paula Nunes; Roberta Diehl Rodriguez; Leonel Takada; Cláudia Kimie Suemoto; Lea Tenenholz Grinberg; Ricardo Nitrini; Beny Lafer
Journal:  Prog Neuropsychopharmacol Biol Psychiatry       Date:  2019-04-20       Impact factor: 5.067

4.  Effect of memantine on C-reactive protein and lipid profiles in bipolar disorder.

Authors:  Hui Hua Chang; Po See Chen; Tzu-Yun Wang; Sheng-Yu Lee; Shiou-Lan Chen; San-Yuan Huang; Jau-Shyong Hong; Yen Kuang Yang; Ru-Band Lu
Journal:  J Affect Disord       Date:  2017-06-09       Impact factor: 4.839

5.  Obesity and brain structure in schizophrenia - ENIGMA study in 3021 individuals.

Authors:  Sean R McWhinney; Katharina Brosch; Vince D Calhoun; Benedicto Crespo-Facorro; Nicolas A Crossley; Udo Dannlowski; Erin Dickie; Lorielle M F Dietze; Gary Donohoe; Stefan Du Plessis; Stefan Ehrlich; Robin Emsley; Petra Furstova; David C Glahn; Alfonso Gonzalez-Valderrama; Dominik Grotegerd; Laurena Holleran; Tilo T J Kircher; Pavel Knytl; Marian Kolenic; Rebekka Lencer; Igor Nenadić; Nils Opel; Julia-Katharina Pfarr; Amanda L Rodrigue; Kelly Rootes-Murdy; Alex J Ross; Kang Sim; Antonín Škoch; Filip Spaniel; Frederike Stein; Patrik Švancer; Diana Tordesillas-Gutiérrez; Juan Undurraga; Javier Váquez-Bourgon; Aristotle Voineskos; Esther Walton; Thomas W Weickert; Cynthia Shannon Weickert; Paul M Thompson; Theo G M van Erp; Jessica A Turner; Tomas Hajek
Journal:  Mol Psychiatry       Date:  2022-06-14       Impact factor: 13.437

6.  Diagnosis of bipolar disorders and body mass index predict clustering based on similarities in cortical thickness-ENIGMA study in 2436 individuals.

Authors:  Sean R McWhinney; Christoph Abé; Martin Alda; Francesco Benedetti; Erlend Bøen; Caterina Del Mar Bonnin; Tiana Borgers; Katharina Brosch; Erick J Canales-Rodríguez; Dara M Cannon; Udo Dannlowski; Ana M Diaz-Zuluaga; Lorielle Dietze; Torbjørn Elvsåshagen; Lisa T Eyler; Janice M Fullerton; Jose M Goikolea; Janik Goltermann; Dominik Grotegerd; Bartholomeus C M Haarman; Tim Hahn; Fleur M Howells; Martin Ingvar; Tilo T J Kircher; Axel Krug; Rayus T Kuplicki; Mikael Landén; Hannah Lemke; Benny Liberg; Carlos Lopez-Jaramillo; Ulrik F Malt; Fiona M Martyn; Elena Mazza; Colm McDonald; Genevieve McPhilemy; Sandra Meier; Susanne Meinert; Tina Meller; Elisa M T Melloni; Philip B Mitchell; Leila Nabulsi; Igor Nenadic; Nils Opel; Roel A Ophoff; Bronwyn J Overs; Julia-Katharina Pfarr; Julian A Pineda-Zapata; Edith Pomarol-Clotet; Joaquim Raduà; Jonathan Repple; Maike Richter; Kai G Ringwald; Gloria Roberts; Alex Ross; Raymond Salvador; Jonathan Savitz; Simon Schmitt; Peter R Schofield; Kang Sim; Dan J Stein; Frederike Stein; Henk S Temmingh; Katharina Thiel; Sophia I Thomopoulos; Neeltje E M van Haren; Holly Van Gestel; Cristian Vargas; Eduard Vieta; Annabel Vreeker; Lena Waltemate; Lakshmi N Yatham; Christopher R K Ching; Ole A Andreassen; Paul M Thompson; Tomas Hajek
Journal:  Bipolar Disord       Date:  2021-12-16       Impact factor: 5.345

7.  Lessons from ecology for understanding the heterogeneity of bipolar disorder.

Authors:  Abraham Nunes; Katie Scott; Martin Alda
Journal:  J Psychiatry Neurosci       Date:  2022-10-18       Impact factor: 5.699

Review 8.  Do the Trajectories of Bipolar Disorder and Schizophrenia Follow a Universal Staging Model?

Authors:  Anne Duffy; Gin S Malhi; Paul Grof
Journal:  Can J Psychiatry       Date:  2016-07-09       Impact factor: 4.356

9.  Exploring brain insulin resistance in adults with bipolar depression using extracellular vesicles of neuronal origin.

Authors:  Rodrigo B Mansur; Francheska Delgado-Peraza; Mehala Subramaniapillai; Yena Lee; Michelle Iacobucci; Flora Nasri; Nelson Rodrigues; Joshua D Rosenblat; Elisa Brietzke; Victoria E Cosgrove; Nicole E Kramer; Trisha Suppes; Charles L Raison; Andrea Fagiolini; Natalie Rasgon; Sahil Chawla; Carlos Nogueras-Ortiz; Dimitrios Kapogiannis; Roger S McIntyre
Journal:  J Psychiatr Res       Date:  2020-12-04       Impact factor: 4.791

10.  Obesity as a Risk Factor for Accelerated Brain Ageing in First-Episode Psychosis-A Longitudinal Study.

Authors:  Sean McWhinney; Marian Kolenic; Katja Franke; Marketa Fialova; Pavel Knytl; Martin Matejka; Filip Spaniel; Tomas Hajek
Journal:  Schizophr Bull       Date:  2021-10-21       Impact factor: 7.348

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.